XHKG8026
Market cap59mUSD
Jan 03, Last price
0.32HKD
1D
3.23%
1Q
25.49%
Jan 2017
40.35%
Name
China Brilliant Global Ltd
Chart & Performance
Profile
China Brilliant Global Limited, an investment holding company, engages in the research and development, design, wholesale, and retail of gold and jewelry, and related ancillary businesses in Hong Kong and the Peoples' Republic of China. The company operates through Gold and Jewellery Business, Lending Business, and Fintech Business segments. It is also involved in the banking activities, such as accepting deposits, granting credits, advising on credit financing, and arranging credit financing, as well as provision of money services; and money lending business. The company was formerly known as Prosten Health Holdings Limited and changed its name to China Brilliant Global Limited in May 2018. China Brilliant Global Limited was incorporated in 1989 and is headquartered in Sheung Wan, Hong Kong. China Brilliant Global Limited is a subsidiary of Brilliant Chapter Limited.
Valuation
Title HKD in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
---|---|---|---|---|---|---|---|---|---|---|
2024‑03 | 2023‑03 | 2022‑03 | 2021‑03 | 2020‑03 | 2019‑03 | 2018‑03 | 2017‑03 | 2016‑03 | 2015‑03 | |
Income | ||||||||||
Revenues | 91,254 -2.85% | 93,930 20.72% | 77,806 31.79% | |||||||
Cost of revenue | 110,015 | 131,379 | 114,839 | |||||||
Unusual Expense (Income) | ||||||||||
NOPBT | (18,761) | (37,449) | (37,033) | |||||||
NOPBT Margin | ||||||||||
Operating Taxes | 3,053 | (17,469) | (15,648) | |||||||
Tax Rate | ||||||||||
NOPAT | (21,814) | (19,980) | (21,385) | |||||||
Net income | (68,926) 69.00% | (40,784) 9.28% | (37,322) -9.09% | |||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
Debt | ||||||||||
Debt current | 65 | 3,313 | 78,504 | |||||||
Long-term debt | 65 | 59,311 | 94 | |||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | (256,112) | 17,535 | (13,546) | |||||||
Cash flow | ||||||||||
Cash from operating activities | 27,422 | (43,352) | (38,275) | |||||||
CAPEX | (76) | (1,837) | (11,382) | |||||||
Cash from investing activities | (83,872) | (2,401) | (11,958) | |||||||
Cash from financing activities | 25,960 | (1,021) | 32,790 | |||||||
FCF | (37,865) | 27,823 | (46,386) | |||||||
Balance | ||||||||||
Cash | 15,248 | 45,089 | 92,144 | |||||||
Long term investments | 240,994 | |||||||||
Excess cash | 251,679 | 40,392 | 88,254 | |||||||
Stockholders' equity | (237,212) | (474,452) | (448,372) | |||||||
Invested Capital | 561,369 | 583,650 | 602,015 | |||||||
ROIC | ||||||||||
ROCE | ||||||||||
EV | ||||||||||
Common stock shares outstanding | 1,457,239 | 1,457,239 | 1,457,239 | |||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | (15,537) | (32,181) | (32,636) | |||||||
EV/EBITDA | ||||||||||
Interest | 484 | 102 | 78 | |||||||
Interest/NOPBT |